ONCOBIOLOGICS INC has a total of 38 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and China. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are METHERESIS TRANSLATIONAL RES S A, AGENUS INC and UBIPROTEIN CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | Canada | 7 | |
#3 | China | 7 | |
#4 | Mexico | 6 | |
#5 | EPO (European Patent Office) | 5 | |
#6 | United States | 4 | |
#7 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Chemical engineering |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Microbiology | |
#6 | Analysing materials | |
#7 | Separation |
# | Name | Total Patents |
---|---|---|
#1 | Gangloff Scott | 15 |
#2 | Taddei Maria | 13 |
#3 | Cheung Jessica | 10 |
#4 | Gutka Hiten | 10 |
#5 | Santoro Marc | 8 |
#6 | Madabhushi Sri | 8 |
#7 | Jose Kevin John | 8 |
#8 | Jerajani Kaushal | 5 |
#9 | Pandey Pradeep | 5 |
#10 | Jang Eun | 5 |
Publication | Filing date | Title |
---|---|---|
CN109073655A | The method of the amino acid sequence of identification and analysis albumen | |
EP3411401A1 | Buffer formulations for enhanced antibody stability | |
MX2018008447A | Modulation of afucosylated species in a monoclonal antibody composition. | |
EP3247718A1 | Modulation of charge variants in a monoclonal antibody composition | |
WO2015057910A1 | Buffer formulations for enhanced antibody stability |